Boiron(OTC) BOIRF

Current Price$31.50

Market Cap$546.91M

Since IPO (2004)+37%

5 Year+5%

1 Year+22%

1 Month+4%

Boiron last closing stock price
Metric	Price	Date
Last close	USD 31.50	2026-07-06

Boiron stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+3.86%	USD 30.33	2026-06-17
1 month	+3.86%	USD 30.33	2026-05-19
3 month	+10.43%	USD 28.52	2026-03-24
Year to date	+10.43%	USD 28.52	2025-11-13
1 year	+22.12%	USD 25.79	2025-05-23
3 year	+4.74%	USD 30.07	2023-06-13
5 year	+4.76%	USD 30.07	2021-05-20
Since inception	+36.66%	USD 23.05	2004-01-07

Boiron Financials at a Glance

Market Cap

$546.91M

Revenue (TTM)

€988.57M

Net Income (TTM)

€43.97M

EPS (TTM)

$2.14

P/E Ratio

14.69

Dividend

$1.57

Beta (Volatility)

-0.01 (Low)

Dividend

$1.57

Beta (Volatility)

-0.01 (Low)

Price

$31.50

Volume

200

Open

$31.50

Price

$31.50

Volume

200

Open

$31.50

Previous Close

$31.50

Daily Range

$31.50 - $31.50

52-Week Range

$24.00 - $32.28

Estimated Earnings Date

Sep 18, 2025

Dividend

$1.57

Beta (Volatility)

-0.01 (Low)

Price

$31.50

Volume

200

Open

$31.50

Previous Close

$31.50

Daily Range

$31.50 - $31.50

52-Week Range

$24.00 - $32.28

Estimated Earnings Date

Sep 18, 2025

BOIRF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Boiron

Boiron S.A. is a prominent pharmaceutical company specializing in the global development and sale of homeopathic treatments. Established in 1932, the company has a significant presence in France, Europe, North America, and various international markets.

Products and Services

Diverse homeopathic products, including Oscillococcinum for flu symptoms
Topical treatments like Arnigel for minor injuries and Stodal for cough relief
Supplementary health products, including dietary supplements and herbal medicines

Growth Outlook

Revenue of 245.6 million EUR in Q2 2025, showing consistent demand
Net income of 11.36 million EUR in Q2 2025, indicating profitability
Strong gross profit margin of 73.7% in Q2 2025, reflecting operational efficiency

Financial Highlights

Trailing twelve months (TTM) revenue of 1.01 billion EUR, demonstrating robust sales
Dividend yield of 4.82% TTM, appealing for income-focused investors
Low debt ratio of 5.2%, indicating strong financial stability

AI Generated • Jun 26, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

2,634

CEO

Pascal Houdayer, MBA

Website

www.boironfinance.com

Headquarters

Messimy, 69510, FR

BOIRF Financials

Key Financial Metrics (TTM)

Gross Margin

72.98%

Operating Margin

7.06%

Net Income Margin

6.51%

Return on Equity

8.57%

Return on Capital

8.34%

Return on Assets

5.41%

Earnings Yield

6.81%

Dividend Yield

4.98%

Payout Ratio

63.83%

Stock Overview

Market Cap

$546.91M

Shares Outstanding

17.36M

Volume

200

Avg. Volume

8.548

Financials (TTM)

Gross Profit

€724.42M

Operating Income

€51.13M

EBITDA

€124.25M

Operating Cash Flow

€95.17M

Capital Expenditure

-€31.41M

Free Cash Flow

€63.76M

Cash & ST Invst.

€79.31M

Total Debt

€31.47M

Boiron Performance Analysis

Boiron annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 561,471,468	4.4%
2023	2023-12-31	EUR 533,258,109	-5.0%
2024	2024-12-31	EUR 527,388,063	-1.1%
2025	2025-12-31	EUR 565,537,183	7.2%

Boiron sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2024-06-30	-9.9%
Q4	2024-12-31	13.5%
Q2	2025-06-30	-5.2%
Q4	2025-12-31	4.0%

Boiron annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR 2.70	40.1%
2023	2023-12-31	EUR 2.23	-17.4%
2024	2024-12-31	EUR 0.71	-68.3%
2025	2025-12-31	EUR 2.12	200.5%

Boiron sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2024-06-30	-83.8%
Q4	2024-12-31	142.1%
Q2	2025-06-30	41.3%
Q4	2025-12-31	89.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

€255.36M

+0.8%

Gross Profit

€184.60M

+0.8%

Gross Margin

72.29%

N/A

Market Cap

$546.91M

N/A

Market Cap/Employee

$221.51K

N/A

Employees

2,469

N/A

Net Income

€21.27M

+4.5%

EBITDA

€35.64M

+4.1%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

€79.31M

+7.1%

Total Debt

€31.47M

+129.7%

Accounts Receivable

€109.45M

+25.9%

Inventory

€98.56M

+1.9%

Long Term Debt

€18.73M

+181.9%

Short Term Debt

€12.74M

+80.5%

Return on Assets

5.41%

N/A

Return on Invested Capital

7.52%

N/A

Free Cash Flow

€15.55M

-33.7%

Operating Cash Flow

€27.51M

-5.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VRNOFVerano Holdings Corp.

VRNOFVerano Holdings Corp.$1.30+8.33%

ELTPElite Pharmaceuticals, Inc.

ELTPElite Pharmaceuticals, Inc.$0.39+4.00%

AGYTFAllergy Therapeutics plc

AGYTFAllergy Therapeutics plc$0.15+0.00%

CLVSFCellaVision AB (publ)

CLVSFCellaVision AB (publ)$14.00+0.00%

GLASFGlass House Brands Inc.

GLASFGlass House Brands Inc.$10.79-8.64%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$9.10-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$16.46-0.01%

TAT&T

TAT&T$24.13+0.05%

FFord Motor Company

FFord Motor Company$14.37+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

Questions About BOIRF

What is the current price of Boiron?

Boiron is trading at $31.50 per share.

What is the 52-week range for Boiron?

Over the past 52 weeks, Boiron has traded between $24.00 and $32.28.

How much debt does Boiron have?

As of the most recent reporting period, Boiron reported total debt of €36.97M.

How much cash does Boiron have on hand?

Boiron reported €93.18M in cash and cash equivalents in its most recent financial results.

What is Boiron’s dividend yield?

Boiron currently has a dividend yield of 4.98%.

Boiron(OTC) BOIRF

Boiron Financials at a Glance

BOIRF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Boiron

BOIRF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Boiron Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BOIRF

What is the current price of Boiron?

What is the 52-week range for Boiron?

How much debt does Boiron have?

How much cash does Boiron have on hand?

What is Boiron’s dividend yield?

Premium Investing Services